Evaluating Clinical Agentic AI Systems in Oncology
AI agents can already write a treatment plan for a lung cancer patient. The harder question is whether their reasoning holds up. My thesis built nsclc-eval, a framework that scores both the reasoning and the final recommendation of LLM agents choosing between immunotherapy alone (IO) and immunotherapy plus chemotherapy (IOCT) for advanced NSCLC.